MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7

Malignant gliomas are the most common tumor in central nervous system with poor prognosis. Due to the limitation of histological classification in earlier diagnosis and individualized medicine, it is necessary to combine the molecular signatures and the pathological characteristics of gliomas. Lots...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhi-Qin, Ren, Jing-Jing, Zhao, Jun-Long, Zang, Jian, Long, Qian-Fa, Du, Jing-Jing, Jia, Xiao-Tao, Gu, Nai-Bing, Di, Zheng-Li, Qian, Yi-Hua, Li, San-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058039/
https://www.ncbi.nlm.nih.gov/pubmed/32139705
http://dx.doi.org/10.1038/s41598-020-60218-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058039/
https://www.ncbi.nlm.nih.gov/pubmed/32139705
http://dx.doi.org/10.1038/s41598-020-60218-9

Ejemplares similares